A PYMNTS Company

UK: CME gets antitrust clearance for $5.5b NEX buy

By  |  October 31, 2018

Britain’s competition watchdog cleared CME Group’s £3.9 billion (US$4.96 billion) deal to buy Michael Spencer’s NEX Group, paving the way for a cross-border trading powerhouse, reported the Financial Times.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The UK Competition and Markets Authority’s (CMA) approval of the £3.9 billion (US$4.96 billion) acquisition was the last significant hurdle for CME and NEX to overcome after receiving the go-ahead from the US Department of Justice earlier this month. CME and NEX announced the news in separate statements on Wednesday, October 31.

    CME announced the pair now expect the deal to close by Friday, November 2. The companies had already received approvals from the Financial Conduct Authority in the UK, and regulators in the US, Germany, Italy, and Sweden.

    The UK CMA’s investigation began in mid-September. The authority had until November 8 to decide whether the deal could damage competition in the market. The deal was not referred for a more rigorous second-phase investigation.

    Full Content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.